Thrombosis and Hemostasis

Thrombosis, the formation of a blood clot inside a blood vessel that obstructs the flow of blood through the circulatory system, is thought to occur when natural hemostatic mechanisms, which help restrict the clot to the site of injury, are genetically impaired or are overwhelmed by the severity of the initial injury. Discover the latest research on hemostasis and thrombosis here.

July 9, 2020
Review

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention

Postępy w kardiologii interwencyjnej = Advances in interventional cardiology
Marek KozińskiAnna Tomaszuk-Kazberuk
July 8, 2020
Open Access

High Incidence of Antiphospholipid Antibodies in Newly Diagnosed Patients With Lymphoma and a Proposed aPL Predictive Score

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Smith KungwankiattichaiTheera Ruchutrakool
July 4, 2020
Review

Roles of Platelet Toll-like Receptors in Thrombosis

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Jie Cao, Renqiang Yang
July 4, 2020
Open Access

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

The Lancet. Haematology
George GoshuaAlfred I Lee
July 2, 2020
Open Access

Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice

TH Open : Companion Journal to Thrombosis and Haemostasis
Stephan V HendriksMenno V Huisman
July 3, 2020

Safety of using the combination of the Wells rule and D-dimer test for excluding acute recurrent ipsilateral deep vein thrombosis

Journal of Thrombosis and Haemostasis : JTH
Lisette F van DamFrederikus A Klok
July 4, 2020
Open Access

COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Erkan Cure, Medine Cumhur Cure
July 4, 2020
Case Report
Open Access

Left atrial appendage thrombus on full-dose dabigatran treatment: a case report

European Heart Journal. Case Reports
Paolo CandelaresiRossella Gottilla
July 3, 2020

Acute kidney injury in decompensated cirrhosis is associated with both hypo- and hyper-coagulable features

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Alberto ZanettoGuadalupe Garcia-Tsao
July 4, 2020
Comment / Editorial
Open Access

COVID-19 and venous thromboembolism: current insights and prophylactic strategies

Annals of Medicine
Pasquale AmbrosinoMatteo Nicola Dario Di Minno
July 8, 2020
Open Access

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Journal of Thrombosis and Thrombolysis
Vera PaarMichael Lichtenauer
July 6, 2020
Review

Antithrombotic therapy after iliac vein stenting

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Wen ZhongHongkun Zhang
July 9, 2020

Invasive liver abscess syndrome accompanied by spondylodiscitis: a case report and review of the literature

Clinical Journal of Gastroenterology
Shun-Ichi WakabayashiAkihiro Iijima

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2020 Meta ULC. All rights reserved
/feed-previews/thrombosis-and-hemostasis/930b3645-f233-4b08-9802-b69f3a0da8e5